BC
WST icon

Barnett & Company’s West Pharmaceutical WST Stock Holding History

Barnett & Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-24
Closed -$4K – 449
2019
Q4 		$4K Buy
24
+23
+2,300% +$3.35K ﹤0.01% 406
2019
Q3 		$0 Buy
+1
New +$138 ﹤0.01% 471

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Barnett & Company's WST Position: Q1 2020 in Review

Barnett & Company sold out of West Pharmaceutical (WST) in Q1 2020, closing a stake of 24 shares — an estimated $4K sold.

Barnett & Company first reported a position in WST in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 468 funds tracked by Wall St. Rank hold WST as of Q1 2020.

  • Barnett & Company reported no remaining West Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Barnett & Company sold 24 West Pharmaceutical shares in Q1 2020, an estimated $4K.
  • Barnett & Company first reported a position in West Pharmaceutical in Q3 2019 and held it in 2 quarters.
  • Barnett & Company's West Pharmaceutical position peaked at $4K in Q4 2019.
  • 468 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Barnett & Company's 13F filing for Q1 2020, filed 23 Apr 2020.